DEF 14A
Teva to raise $2.06B in sustainability-linked senior notes offering, launches $2.25B in debt tender offers for notes
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Amid challenging market, Teva chips away at debt mountain
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Can Teva's Debt Repayment Plan Deleverage Its Balance Sheet?
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Teva's (TEVA) Massive Debt Load Just Became an Even Bigger Issue - TheStreet
Teva Raises $2.1 Billion in Debt Tender Offer | Ctech
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva Pharmaceutical to sell assets such as women's health unit to cut debt | Mint
Running out of time and money, CEO to prioritize getting Teva out of the hole | The Times of Israel
Teva Pharmaceutical or Mylan: Which Has the Better Debt Profile?
Why Long-Term Investors Should Avoid Teva Stock | The Motley Fool
Teva's Working With Evercore to Review Debt Options - Bloomberg
Billionaire Businessman Looking to Take Stake in Debt-Ridden Teva | BioSpace
Teva (TEVA) Stock Is Still Facing Major Risk at This Point | InvestorPlace
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement - FactEntry
Teva CEO Resigns; Dividend Cut Should Be Next - Bloomberg
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
Mylan/Viatris and Teva at the 38th Annual J.P. Morgan Healthcare Conference - MidgardFinance.com
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption (NYSE: TEVA) | Seeking Alpha
Teva Avoids Bankruptcy, Huge Upside (NYSE:TEVA) | Seeking Alpha
Legal Troubles Could Weigh Down Teva's Ability to Carry its Debt Covenants | Ctech
